Dysregulated Bone Morphogenetic Protein Signaling in Monocrotaline-Induced Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Dysregulated Bone Morphogenetic Protein Signaling in Monocrotaline-Induced Pulmonary Arterial Hypertension

Published:2007-05 Issue:5 Volume:27 Page:1072-1078
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:ATVB

Author:

Morty Rory E.¹,Nejman Bozena¹,Kwapiszewska Grazyna¹,Hecker Matthias¹,Zakrzewicz Anka¹,Kouri Fotini M.¹,Peters Dorothea M.¹,Dumitrascu Rio¹,Seeger Werner¹,Knaus Petra¹,Schermuly Ralph T.¹,Eickelberg Oliver¹

Affiliation:

1. From the Department of Internal Medicine (R.M., B.N., G.K., M.H., A.Z., F.K., D.P., R.D., W.S., R.S., O.E.), University of Giessen Lung Center, Justus Liebig University, Giessen; and the Institute of Chemistry and Biochemistry (P.K.), Free University of Berlin, Germany.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Pulmonary Arterial Hypertension

2. Cellular and molecular pathobiology of pulmonary arterial hypertension

3. Pathobiology of pulmonary arterial hypertension

4. The tantalizing triplet of pulmonary hypertension—BMP receptors, serotonin receptors, and angiopoietins

5. BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Musculoskeletal crosstalk in chronic obstructive pulmonary disease and comorbidities: Emerging roles and therapeutic potentials;Pharmacology & Therapeutics;2024-05

2. Hemodynamic and Clinical Profiles of Pulmonary Arterial Hypertension Patients with GDF2 and BMPR2 Variants;International Journal of Molecular Sciences;2024-02-27

3. Pulmonary arterial hypertension: Sex matters;British Journal of Pharmacology;2024-01-16

4. Transcriptional profiles of pulmonary artery endothelial cells in pulmonary hypertension;Scientific Reports;2023-12-18

5. Metabolic reprogramming, oxidative stress, and pulmonary hypertension;Redox Biology;2023-08